Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 2, 1999, Pages 199-208

  Rajah, Roopmathy ^a   Nachajon, Roberto V ^a   Collins, Margaret H ^a   Hakonarson, Hakon ^a   Grunstein, Michael M ^a   Cohen, Pinchas ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; INTERSTITIAL COLLAGENASE; RECOMBINANT PROTEIN; SOMATOMEDIN BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; ENZYMOLOGY; FEMALE; HUMAN; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE; TRACHEA;

ADOLESCENT; ADULT; ASTHMA; CHILD; COLLAGENASES; FEMALE; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; MATRIX METALLOPROTEINASE 1; MUSCLE, SMOOTH; RECOMBINANT PROTEINS; TRACHEA;

EID: 0033071048     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.2.3148     Document Type: Article

References (53)

1. LeRoith, D., H. Werner, B. Burguera, C. T. Roberts, S. Mulroney, and A. Haramati. 1992. The insulin-like growth factor family of peptides, binding proteins and receptors: their potential role in tissue regeneration. Adv. Exp. Med. Biol. 321:21-28.
2. Rotwein, P. 1991. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5:3-18.
3. Baserga, R., P. Porcu, M. Ruhini, and C. Sell. 1993. Cell cycle control by the IGF-1 receptor and its ligands. Adv. Exp. Med. Biol. 343:105-112.
4. Cohen, P., D. M. Peehl, G. Lamson, and R. G. Rosenfeld. 1991. Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells, J Clin. Endocrinol. Metab. 73:401-407.
5. Cohen, P., P. J. Fielder, Y. Hasegawa, H. Frisch, L. C. Giudice, and R. G. Rosenfeld. 1991. Clinical aspects of insulin-like growth factor binding proteins. Acta fendocrinol. (Copenh) 124(Suppl. 2):74-85.
6. Jones, J. I., and D. R. Clemmons. 1995. Insulin-like growth factors and their binding proteins: biological actions, Endocr. Rev. 16:3-34.
7. Rosenfeld, R. G., H. Pham, P. Cohen, P. Fielder, S. F. Gargoskey, H. Muller, L. Nonoshita, and Y. Oh. 1994. Physiology of the insulin-like growth factor binding proteins. Acta Paediatr. Suppl. 399:154-158.
8. Giudice, L. C., B. A. Dsupin, I. H. Jin, T. H. Vu and A. R. Hoffman. 1993. Differential expression of messenger ribonucleic acids encoding insulin-like growth factors and their receptors in human uterine endometrium and decidua. J. Clin. Endocrinol. Metab. 76:1115-1122.
9. Cohen, P., H. C. B. Graves, D. M. Peehl, M. Kamarei, L. C. Giudice, and R. G. Rosenfeld. 1992. Prostate specific antigen (PSA) is an IGF binding protein-3 (IGFBP-3) protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75:1046-1053.
10. Giudice. L. C. 1995. IGF binding protein-3 protease regulation: how sweet it is. J. Clin. Endocrinol. Metab. 80:2279-2281.
11. Cohen, P., D. M. Peehl, H. C. B. Graves, and R. G. Rosenfeld. 1994. Biological effects of prostate specific antigen (PSA) as an TGF binding protein-3 (IGFBP-3)protease. J. Endocrinol 142:407-415.
12. Fielder, P. J., R. G. Rosenfeld, and P. Cohen. 1994. Biochemical analysis of PSA proteolyzed IGFBP-3. Growth Regul. 4:164-172.
13. Palka, J., E. Bankowski, and M. Wolanska. 1993. Changes in IGF-binding proteins in rats with experimental diabetes. Ann. Biol. Clin. (Paris) 51: 701-706.
14. Conover, C. A., J. E. Perry, and D. Tindall. 1995. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J. Clin. Endocrinol. Metab. 80: 987-993.
15. Conover, C. A., and D. D. De Leon. 1994. Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells: role of cathepsin D. J. Biol. Chem. 269:7076-7080.
16. Fowlkes, J. L., K. Suzuki. II. Nagase, and K. M. Thrailkill. 1994. Protcolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinology 135:2810-2813.
17. Fowlkes, J. L., J. J. Enghild, K. Suzuki, and H. Nagase. 1994. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269:25742-25746.
18. Parker, A., A. Gockerman, W. H. Busby, and D. R. Clemmons. 1995. Properties of an insulin-like growrth factor-binding protein-4 protease that is secreted by smooth muscle cells. Endocrinology 136:2470-2476.
19. Cohick, W. S., A.Gockerman, and D. R. Clemmons. 1995. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by scrum deprivation in vascular smooth muscle cells. J. Cell. Physiol. 164:187-196.
20. Kamyar, A., C. J. Pirola, H. M. Wang, B. Sharifi, S. Mohan, J. S. Forrester, and J. A. Fagin. 1994. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells. Circ. Res. 74:576-585.
21. Gockerman, A., and D. R. Clemmons. 1995. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2. Circ. Res. 76:514-521.
22. Delafontaine, P., X. P. Meng. L. Ku, and J. Du. 1995. Regulation of vascular smooth muscle cell insulin-like growth factor receptors by phosphorothioate oligonuclcotides: effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. J. Biol. Chem. 270: 14383-14388.
23. Du, J., and P. Delafontaine. 1945. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. Circ. Res. 76:963-972.
24. Vervetis, J. J., L. Ku, and P. Delafontaine. 1993. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ. Res. 72:1285-1292.
25. Taylor, W. R., R. M. Nerem, and R. W. Alexander. 1993. Polarized secretion of IGF-I and IGF-I binding protein activity by cultured aortic endothelial cells. J. Cell. Physiol. 154:139-142.
26. Giannella-Neto, D., A. Kamyar, B. Sharifi, C. J. Pirola, J. Kupfer, R. G. Rosenfeld, J. S. Forrester, and J. A. Fagin. 1992. Platelet-derived growth factor isoforms decrease insulin-like growth factor T gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4. Circ. Res. 71:646-656.
27. Delafontaine, P., H. Lou, and R. W. Alexander. 1991. Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 18:742-747.
28. McCusker, R. H., and D. R. Clemmons. 1994. Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro. Endocrinology 134:2095-2102.
29. Ferns, G. A., A. S. Motani, and E. E. Anggard. 1991. The insulin-like growth factors: their putative role in atherogencsis. Artery 18:197-225.
30. Nakao-Hayashi, J., H. Ito, T. Kanayasu, I. Morita, and S. Murota. 1992. Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells. Atherosclerosis 92:141-149.
31. Bailey, W. L., D. W. LaFleur, J. S. Forrester, J. A. Fagin, and B. G. Sharifi. 1994. Stimulation of rat vascular smooth muscle cell glycosaminoglycan production by angiotensin II. Atherosclerosis 111:55-64.
32. Stiles, A., and J. D'Ercole. 1990. The insulin-like growth factors and the lung. Am. J. Respir. Cell Mol. Biol. 3:93-100.
33. Jeffety, P. K. 1994. Comparative morphology of the airways in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150 (Suppl.):S6-S13.
34. Henderson, W. R., Jr. 1991. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am. Rev. Respir. Dis. 143(Suppl.):S86-S90.
35. Huang. S. K., H. Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, and M. C. Liu. 1995. IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. 155:2688-2694.
36. Bradding, P., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mucller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell. Mol. Biol. 10:471-180.
37. Bentley, A. M., Q. Meng, D. S. Robinson, O. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, cosinophils, and cytokine mRNA expression for intedeukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
38. Marini, M., E. Vittori, J. Hollemborg, and S. Mattoli. 1992. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89;1001-1009.
39. Noveral, J. V., A. Bhala, M. Grunstein, and P. Cohen. 1994. The insulin-like growth factor axis in airway smooth muscle cells. Am. J. Physiol. 267(Lung Cell. Mol. Physiol.):761-765.
40. 4 on the proliferation of airway smooth muscle cells are mediated by modulation of the IGF axis. Am. J. Physiol. 269: L151-L157.
41. Rajah, R., S. Nunn, D. Herrick, M. M. Grunstein, and P. Cohen. 1996. LTD-4 induces matrix metalloproteinase-1 which functions as an IGFBP protease in airway smooth muscle cells. Am. J. Physoil. 271:L1014-L1022.
42. Lamson, G., P. Cohen, L. C. Guidice, P. J. Fielder, Y. Oh, R. L. Hintz, and K. G. Rosenfeld. 1993. Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul. 3:91-95.
43. Lamson, G., L. C. Giudice, and R. G. Rosenfeld. 1991. A simple assay for proteolysis of IGFBP-3. J. Clin. Endocrinol. Metab. 72:1391-1393.
44. Casini, A., E. Ceni, R. Salzano, S. Milani, D. Schuppan, and C. Surrenti. 1994. Acctaldehyde regulates the gene espession of matrix-metalloproteinase-1 and -2 in human fat-storing cells. Life Sci. 55; 1311-1316.
45. Yateman, M. E., D. C. Claffey, S, C. C. Hughes, V. J. Frost, J. A. H. Wass, and J. M. H. Holly. 1993. Cytokines modulate the sensitivity of human fibroblasts to stimulation with IGF-I by altering endogenous IGFBP production. J. Endocrinol. 137:151-159.
46. Bachrach, L. K., and M. Eggo. 1989. Characterization of insulin-like growth factors from sheep thyroid cells. Endocrinology 125:2831-2838.
47. Smith, E. P., B. A. Dickson, and S. D. Chernausek. 1990. Insulin-like growth factor binding protein-3 secretion from cultured rat Sertoli cells: dual regulation by follicle stimulating hormone and insulin-like growth factor-1, Endocrinology 127:2744-2751.
48. Adashi, E. Y., C. E. Resnick, A. Hurwitz, E. Ricciarelli, E. R. Hernandez, and R. G. Rosenfeld. 1991. Ovarian granulosa cell-derived insulin-like growth factor binding proteins: modulatory role of follicle stimulating hormone. Endocrinology 128:754-760.
49. Scharla, S. H., D. D. Strong, S. Mohan, D. J. Baylink, and T. A. Linkhart. 1991. 1,25-Dihydroxy vitamin D3 differentially regulates the production of insulin-like growlh factors-1 (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146.
50. Durham, S. K., B. L. Riggs, and C. A. Conover. 1994. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta. J. Clin. Endocrinol. Metab. 79:1752-1758.
51. Fielder, P. J., H. Pham, E. Y. Adashi, and R. G. Rosenfeld. 1993. Insulin-like growth factors (IGFs) block FSH-induced proteolysis of IGF-binding protein-5 (BP-5) in cultured rat granulosa cells. Endocrinology 133:415-418.
52. Tamai, K. H., A. Ishikawa, A., and J. U. Mauviel. 1995. Interferon-gamma coordmately upregulates matrix mctalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keralinocytes. J. Invest. Dermatol. 104;384-390.
53. Muir, D. 1995. Differences in proliferation and invasion by normal, transformed and NM Schwann cell cultures are influenced by matrix metalloproteinase expression. Clin. Exp. Metastasis 13:303-314.